tu2670
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 19, 2021 (NCT05138562)
Timeline
Indications
Studied for
Mechanism of action
- Gonadotropin-releasing hormone receptorANTAGONIST
GNRHR antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07264192 | Phase 1 | Mar 11, 2025 | Jiangsu Hansoh Pharmaceutical Co., Ltd., Sichuan University |
| NCT06554548 | Phase 1 | Aug 15, 2024 | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
| NCT06118827 | Phase 1 | Nov 1, 2023 | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
| NCT05138562 | Phase 2 | Aug 19, 2021 | TiumBio Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | For profit | 3 | 2 | 1 | 2023 |
| Sichuan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| TiumBio Co., Ltd. | For profit | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1